Antimicrobial drug developer HOOKIPA Pharma (NASDAQ:HOOK) announced Thursday that Gilead Sciences (NASDAQ:GILD) has agreed to ...

Gilead Sciences is paying $10 million for sole ownership of arenavirus immunotherapies for hepatitis B (HBV) and HIV ...

Shares of Gilead Sciences Inc. advanced 3.57% to $106.16 Monday, on what proved to be an all-around great trading session for ...

The stock's fall snapped a four-day winning streak.

The end is almost here for the heroes and villains of Gilead and beyond. The penultimate episode "Execution" not only lives ...